As of 2025-05-16, the Intrinsic Value of Immunic Inc (IMUX) is -5.24 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.00 USD, the upside of Immunic Inc is -626.72%.
Based on its market price of 1.00 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 626.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.24 - -5.24 | -5.24 | -626.72% |
| P/E | (10.51) - (20.08) | (16.76) | -1782.9% |
| DDM - Stable | (6.42) - (26.21) | (16.31) | -1738.5% |
| DDM - Multi | (2.15) - (7.43) | (3.40) | -441.9% |
| Market Cap (mil) | 95.41 |
| Beta | 1.22 |
| Outstanding shares (mil) | 95.82 |
| Enterprise Value (mil) | 59.74 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.52% |
| Cost of Debt | 5.00% |
| WACC | 7.60% |